{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:07Z","timestamp":1787003827758,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA062173"],"award-info":[{"award-number":["K23DA062173"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50MH126283"],"award-info":[{"award-number":["P50MH126283"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50MH126283"],"award-info":[{"award-number":["P50MH126283"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG51108"],"award-info":[{"award-number":["T32AG51108"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mental Health"],"DOI":"10.1038\/s44220-026-00673-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:02:50Z","timestamp":1781859770000},"page":"1122-1129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emergency department use by individuals with and without psychosis after state-level cannabis legalization and commercialization"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-6195","authenticated-orcid":false,"given":"Andrew S.","family":"Hyatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael William","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Overhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danta","family":"Bien-Aime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Eden","family":"Evins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L\u00ea","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"673_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","volume":"382","author":"L Degenhardt","year":"2013","unstructured":"Degenhardt, L. et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382, 1564\u20131574 (2013).","journal-title":"Lancet"},{"key":"673_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(17)32366-8","volume":"390","author":"E Gakidou","year":"2017","unstructured":"Gakidou, E. et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1345\u20131422 (2017).","journal-title":"Lancet"},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow, N. D. et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry 73, 292\u2013297 (2016).","journal-title":"JAMA Psychiatry"},{"key":"673_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115626","volume":"331","author":"JM Groening","year":"2024","unstructured":"Groening, J. M. et al. A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 331, 115626 (2024).","journal-title":"Psychiatry Res."},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S2215-0366(22)00161-4","volume":"9","author":"K Petrilli","year":"2022","unstructured":"Petrilli, K. et al. Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry 9, 736\u2013750 (2022).","journal-title":"Lancet Psychiatry"},{"key":"673_CR6","doi-asserted-by":"publisher","unstructured":"Hjorth\u00f8j, C. et al. Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychol. Med. https:\/\/doi.org\/10.1017\/S0033291723000880 (2023).","DOI":"10.1017\/S0033291723000880"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00406-019-01068-z","volume":"270","author":"A Hasan","year":"2020","unstructured":"Hasan, A. et al. Cannabis use and psychosis: a review of reviews. Eur. Arch. Psychiatry Clin. Neurosci. 270, 403\u2013412 (2020).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"673_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","volume":"3","author":"T Schoeler","year":"2016","unstructured":"Schoeler, T. et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry 3, 215\u2013225 (2016).","journal-title":"Lancet Psychiatry"},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","volume":"73","author":"T Schoeler","year":"2016","unstructured":"Schoeler, T. et al. Association between continued cannabis use and risk of relapse in first-episode psychosis: a quasi-experimental investigation within an observational study. JAMA Psychiatry 73, 1173\u20131179 (2016).","journal-title":"JAMA Psychiatry"},{"key":"673_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.schres.2014.01.014","volume":"153","author":"I Tarricone","year":"2014","unstructured":"Tarricone, I. et al. The impact of substance use at psychosis onset on first episode psychosis course: results from a 1 year follow-up study in Bologna. Schizophr Res. 153, 60\u201363 (2014).","journal-title":"Schizophr Res."},{"key":"673_CR11","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","volume":"6","author":"R Patel","year":"2016","unstructured":"Patel, R. et al. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open 6, e009888 (2016).","journal-title":"BMJ Open"},{"key":"673_CR12","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1017\/S0033291714000191","volume":"44","author":"E Manrique-Garcia","year":"2014","unstructured":"Manrique-Garcia, E. et al. Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol. Med. 44, 2513\u20132521 (2014).","journal-title":"Psychol. Med."},{"key":"673_CR13","unstructured":"Marijuana Policy Project: state policy. Marijuana Policy Project https:\/\/www.mpp.org\/states\/ (accessed 13 February 2025)."},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","volume":"77","author":"M Cerd\u00e1","year":"2020","unstructured":"Cerd\u00e1, M. et al. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA Psychiatry 77, 165\u2013171 (2020).","journal-title":"JAMA Psychiatry"},{"key":"673_CR15","doi-asserted-by":"publisher","unstructured":"Barret, W. M., Megan, H. R., Claire, E. M. & James, C. A. Estimating the effects of legalizing recreational cannabis on newly incident cannabis use. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0271720 (2022).","DOI":"10.1371\/journal.pone.0271720"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"e2520093","DOI":"10.1001\/jamanetworkopen.2025.20093","volume":"8","author":"AS Hyatt","year":"2025","unstructured":"Hyatt, A. S., Overhage, L. & Cook, B. L. Use of tobacco and cannabis following state-level cannabis legalization. JAMA Netw Open 8, e2520093 (2025).","journal-title":"JAMA Netw Open"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamapsychiatry.2023.0019","volume":"80","author":"DS Hasin","year":"2023","unstructured":"Hasin, D. S. et al. State cannabis legalization and cannabis use disorder in the US Veterans Health Administration, 2005 to 2019. JAMA Psychiatry 80, 380\u2013388 (2023).","journal-title":"JAMA Psychiatry"},{"key":"673_CR18","doi-asserted-by":"publisher","unstructured":"Hyatt, A. S. et al. Cannabis use among individuals with psychosis after state-level commercial cannabis legalization. JAMA Psychiatry https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2539 (2025).","DOI":"10.1001\/jamapsychiatry.2025.2539"},{"key":"673_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","volume":"77","author":"RM Murray","year":"2020","unstructured":"Murray, R. M. & Hall, W. Will legalization and commercialization of cannabis use increase the incidence and prevalence of psychosis? JAMA Psychiatry 77, 777\u2013778 (2020).","journal-title":"JAMA Psychiatry"},{"key":"673_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/0706743720984684","volume":"66","author":"C Vignault","year":"2021","unstructured":"Vignault, C. et al. The potential impact of recreational cannabis legalization on the prevalence of cannabis use disorder and psychotic disorders: a retrospective observational study. Can. J. Psychiatry 66, 1069\u20131076 (2021).","journal-title":"Can. J. Psychiatry"},{"key":"673_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114387","volume":"308","author":"LV Moran","year":"2022","unstructured":"Moran, L. V., Tsang, E. S., Ongur, D., Hsu, J. & Choi, M. Y. Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States. Psychiatry Res. 308, 114387 (2022).","journal-title":"Psychiatry Res."},{"key":"673_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112719","volume":"273","author":"S Joshi","year":"2025","unstructured":"Joshi, S. et al. Changes in psychosis-related emergency department and hospitalization rates among youth following cannabis legalization in Colorado. Drug Alcohol Depend. 273, 112719 (2025).","journal-title":"Drug Alcohol Depend."},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"e2252689","DOI":"10.1001\/jamanetworkopen.2022.52689","volume":"6","author":"H Elser","year":"2023","unstructured":"Elser, H. et al. State cannabis legalization and psychosis-related health care utilization. JAMA Netw Open 6, e2252689 (2023).","journal-title":"JAMA Netw Open"},{"key":"673_CR24","unstructured":"Canadian Department of Justice. Cannabis Legalization and Regulation https:\/\/www.justice.gc.ca\/eng\/cj-jp\/cannabis\/ (2021)."},{"key":"673_CR25","doi-asserted-by":"publisher","first-page":"e2457868","DOI":"10.1001\/jamanetworkopen.2024.57868","volume":"8","author":"DT Myran","year":"2025","unstructured":"Myran, D. T. et al. Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. JAMA Netw Open 8, e2457868 (2025).","journal-title":"JAMA Netw Open"},{"key":"673_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/07067437211070650","volume":"67","author":"RC Callaghan","year":"2022","unstructured":"Callaghan, R. C. et al. Associations between Canada\u2019s cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia conditions: Ontario and Alberta, 2015\u20132019. Can. J. Psychiatry 67, 616\u2013625 (2022).","journal-title":"Can. J. Psychiatry"},{"key":"673_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104285","volume":"123","author":"KK Anderson","year":"2024","unstructured":"Anderson, K. K. et al. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada. Int. J. Drug Policy 123, 104285 (2024).","journal-title":"Int. J. Drug Policy"},{"key":"673_CR28","doi-asserted-by":"publisher","unstructured":"Kim, C., Bai Y., Cao P., Ienciu K. & Chum A. The impact of recreational cannabis legalization on cannabis-related acute care events among adults with schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. https:\/\/doi.org\/10.1007\/s00127-024-02773-4 (2024).","DOI":"10.1007\/s00127-024-02773-4"},{"key":"673_CR29","doi-asserted-by":"publisher","first-page":"e2336113","DOI":"10.1001\/jamanetworkopen.2023.36113","volume":"6","author":"DT Myran","year":"2023","unstructured":"Myran, D. T., Gaudreault, A., Konikoff, L., Talarico, R. & Liccardo Pacula, R. Changes in cannabis-attributable hospitalizations following nonmedical cannabis legalization in Canada. JAMA Netw Open 6, e2336113 (2023).","journal-title":"JAMA Netw Open"},{"key":"673_CR30","doi-asserted-by":"publisher","first-page":"e212545","DOI":"10.1001\/jamanetworkopen.2021.2545","volume":"4","author":"JK Johnson","year":"2021","unstructured":"Johnson, J. K. & Doonan, S. M. Cannabis policy heterogeneity and effects on research\u2014complexity expected. JAMA Netw Open 4, e212545 (2021).","journal-title":"JAMA Netw Open"},{"key":"673_CR31","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2014.16153","volume":"312","author":"JB Dimick","year":"2014","unstructured":"Dimick, J. B. & Ryan, A. M. Methods for evaluating changes in health care policy: the difference-in-differences approach. JAMA 312, 2401\u20132402 (2014).","journal-title":"JAMA"},{"key":"673_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-12-32","volume":"12","author":"JM Olivares","year":"2013","unstructured":"Olivares, J. M., Sermon, J., Hemels, M. & Schreiner, A. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Ann. Gen. Psychiatry 12, 32 (2013).","journal-title":"Ann. Gen. Psychiatry"},{"key":"673_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pam.21804","volume":"34","author":"RL Pacula","year":"2015","unstructured":"Pacula, R. L., Powell, D., Heaton, P. & Sevigny, E. L. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J. Policy Anal. Manag. 34, 7\u201331 (2015).","journal-title":"J. Policy Anal. Manag."},{"key":"673_CR34","doi-asserted-by":"publisher","unstructured":"Hawkins, S. S., Baidoo, C. E., Coley, R. L., Centanni, R. S. & Baum, C. F. The impact of recreational cannabis legalization on cannabis use in US Adults from 2016 to 2023: a quasi-experimental study. Am. J. Prev. Med. https:\/\/doi.org\/10.1016\/j.amepre.2025.108221 (2026).","DOI":"10.1016\/j.amepre.2025.108221"},{"key":"673_CR35","doi-asserted-by":"publisher","first-page":"e2457876","DOI":"10.1001\/jamanetworkopen.2024.57876","volume":"8","author":"JM Gilman","year":"2025","unstructured":"Gilman, J. M. Association of cannabis legalization with prevalence of schizophrenia\u2014challenges of attributing biological causality to policy change. JAMA Netw Open 8, e2457876 (2025).","journal-title":"JAMA Netw Open"},{"key":"673_CR36","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41380-023-02185-x","volume":"28","author":"DT Myran","year":"2023","unstructured":"Myran, D. T. et al. Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis. Mol. Psychiatry 28, 4251\u20134260 (2023).","journal-title":"Mol. Psychiatry"},{"key":"673_CR37","doi-asserted-by":"publisher","first-page":"e220292","DOI":"10.1001\/jamahealthforum.2022.0292","volume":"3","author":"J Purtle","year":"2022","unstructured":"Purtle, J., Brinson, K. & Stadnick, N. A. Earmarking excise taxes on recreational cannabis for investments in mental health: an underused financing strategy. JAMA Health Forum 3, e220292 (2022).","journal-title":"JAMA Health Forum"},{"key":"673_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2023.107617","volume":"140","author":"DS Hasin","year":"2023","unstructured":"Hasin, D. S. et al. Adult use of highly-potent \u03949-THC cannabis concentrate products by US state cannabis legalization status, 2021. Addict. Behav. 140, 107617 (2023).","journal-title":"Addict. Behav."},{"key":"673_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","volume":"6","author":"M Di Forti","year":"2019","unstructured":"Di Forti, M. et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry 6, 427\u2013436 (2019).","journal-title":"Lancet Psychiatry"},{"key":"673_CR40","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1017\/S0033291720000082","volume":"51","author":"D Quattrone","year":"2021","unstructured":"Quattrone, D. et al. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case\u2013control study. Psychol. Med. 51, 1329\u20131337 (2021).","journal-title":"Psychol. Med."},{"key":"673_CR41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamapsychiatry.2021.1471","volume":"78","author":"C Hjorth\u00f8j","year":"2021","unstructured":"Hjorth\u00f8j, C., Posselt, C. M. & Nordentoft, M. Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark. JAMA Psychiatry 78, 1013\u20131019 (2021).","journal-title":"JAMA Psychiatry"},{"key":"673_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.15288\/jsad.23-00277","volume":"85","author":"BH Carlini","year":"2024","unstructured":"Carlini, B. H., Kellum, L. B., Garrett, S. B. & Nims, L. N. Threaten, distract, and discredit: cannabis industry rhetoric to defeat regulation of high-THC cannabis products in Washington State. J. Stud. Alcohol Drugs 85, 322\u2013329 (2024).","journal-title":"J. Stud. Alcohol Drugs"},{"key":"673_CR43","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2105\/AJPH.2018.304401","volume":"108","author":"RA Barry","year":"2018","unstructured":"Barry, R. A. & Glantz, S. A. Marijuana regulatory frameworks in four US states: an analysis against a public health standard. Am. J. Public Health 108, 914\u2013923 (2018).","journal-title":"Am. J. Public Health"},{"key":"673_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/add.16132","volume":"118","author":"B Han","year":"2023","unstructured":"Han, B. & Shi, Y. Associations of recreational cannabis dispensaries\u2019 availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States. Addiction 118, 1270\u20131279 (2023).","journal-title":"Addiction"},{"key":"673_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2023.107696","volume":"143","author":"CJ Berg","year":"2023","unstructured":"Berg, C. J. et al. Cannabis retailer marketing strategies and regulatory compliance: a surveillance study of retailers in 5 US cities. Addict. Behav. 143, 107696 (2023).","journal-title":"Addict. Behav."},{"key":"673_CR46","doi-asserted-by":"publisher","first-page":"S681","DOI":"10.2105\/AJPH.2024.307722","volume":"114","author":"CJ Meek","year":"2024","unstructured":"Meek, C. J. et al. Regulatory landscape of cannabis warning labels in US states with legal retail nonmedical cannabis, 2024. Am. J. Public Health 114, S681\u2013S684 (2024).","journal-title":"Am. J. Public Health"},{"key":"673_CR47","doi-asserted-by":"publisher","unstructured":"US Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse & Food and Drug Administration. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files (ICPSR 36231) https:\/\/doi.org\/10.3886\/ICPSR36231.v36 (2023).","DOI":"10.3886\/ICPSR36231.v36"},{"key":"673_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/070674370905400709","volume":"54","author":"KA McMillan","year":"2009","unstructured":"McMillan, K. A., Enns, M. W., Cox, B. J. & Sareen, J. Comorbidity of axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Can. J. Psychiatry 54, 477\u2013486 (2009).","journal-title":"Can. J. Psychiatry"},{"key":"673_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2013.10.018","volume":"151","author":"GP Davis","year":"2013","unstructured":"Davis, G. P., Compton, M. T., Wang, S., Levin, F. R. & Blanco, C. Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr. Res. 151, 197\u2013202 (2013).","journal-title":"Schizophr. Res."},{"key":"673_CR50","doi-asserted-by":"publisher","first-page":"e234995","DOI":"10.1001\/jamanetworkopen.2023.4995","volume":"6","author":"B Han","year":"2023","unstructured":"Han, B. et al. Tobacco use, nicotine dependence, and cessation methods in US Adults with psychosis. JAMA Netw Open 6, e234995 (2023).","journal-title":"JAMA Netw Open"},{"key":"673_CR51","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Alcohol Policy Information System: Recreational use of Cannabis https:\/\/alcoholpolicy.niaaa.nih.gov\/cannabis-policy-topics\/recreational-use-of-cannabis-volume-1\/104 (accessed 4 October 2024)."},{"key":"673_CR52","unstructured":"Marijuana Policy Project: state policy; https:\/\/www.mpp.org\/states\/ (accessed 30 August 2024)."},{"key":"673_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/qjec.122.1.1","volume":"122","author":"A Finkelstein","year":"2007","unstructured":"Finkelstein, A. The aggregate effects of health insurance: evidence from the introduction of Medicare. Q. J. Econ. 122, 1\u201337 (2007).","journal-title":"Q. J. Econ."},{"key":"673_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jeconom.2020.12.001","volume":"225","author":"B Callaway","year":"2021","unstructured":"Callaway, B. & Sant\u2019Anna, P. H. C. Difference-in-differences with multiple time periods. J. Econom. 225, 200\u2013230 (2021).","journal-title":"J. Econom."},{"key":"673_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-publhealth-040617-013507","volume":"39","author":"C Wing","year":"2018","unstructured":"Wing, C., Simon, K. & Bello-Gomez, R. A. Designing difference in difference studies: best practices for public health policy research. Annu. Rev. Public Health 39, 453\u2013469 (2018).","journal-title":"Annu. Rev. Public Health"},{"key":"673_CR56","doi-asserted-by":"publisher","unstructured":"Freyaldenhoven S., Hansen C., P\u00e9rez P\u00e9rez J., Shapiro J. M. Visualization, Identification, and Estimation in the Linear Panel Event-Study Design; https:\/\/doi.org\/10.3386\/w29170 (National Bureau of Economic Research, 2021).","DOI":"10.3386\/w29170"},{"key":"673_CR57","unstructured":"StataCorp. Stata Statistical Software: Release 19 (StataCorp LLC, 2025)."}],"container-title":["Nature Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00673-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:02:05Z","timestamp":1783461725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1038\/s44220-026-00673-x","relation":{},"ISSN":["2731-6076"],"issn-type":[{"value":"2731-6076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}